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Introduction
Nonalcoholic fatty liver disease (NAFLD) is an emerging health 
epidemic with a poorly understood pathogenesis.1 NAFLD com-
prises a spectrum of hepatic lesions ranging from steatosis with 
deposition of triglycerides within hepatocytes to the more aggres-
sive nonalcoholic steatohepatitis (NASH), which includes hepati-
tis and fibrosis.1,2 Fatty liver disease is highly prevalent in the US, 
with an estimated 30% of the population possessing NAFLD 
and 6% suffering from NASH. These numbers rise to 90% and 
30% respectively when obese populations are examined.3 NASH-
induced complications are severe, and approximately one-third 
Steatoapoptosis is a hallmark of non-alcoholic fatty liver disease (NAFLD) and is an important factor in liver disease 
progression. We hypothesized that increased reactive oxygen species resulting from excess dietary fat contribute to liver 
disease by causing DNA damage and apoptotic cell death and tested this by investigating the effects of feeding mice high-
fat or standard diets for 8 weeks. High-fat diet feeding resulted in increased hepatic H2o2, superoxide production and 
expression of oxidative stress response genes, confirming that the high-fat diet induced hepatic oxidative stress. High-fat 
diet feeding also increased hepatic steatosis, hepatitis and DNA damage as exemplified by an increase in the percentage 
of 8-hydroxyguanosine (8-oHG)-positive hepatocytes in high-fat diet-fed mice. Consistent with reports that the DNA 
damage checkpoint kinase ataxia telangiectasia mutated (AtM) is activated by oxidative stress, AtM phosphorylation 
was induced in the livers of wild-type mice following high-fat diet feeding. We therefore examined the effects of high-fat 
diet feeding in Atm-deficient mice. the prevalence of apoptosis and expression of the pro-apoptotic factor pUMA were 
significantly reduced in Atm-deficient mice fed the high-fat diet when compared with wild-type controls. Furthermore, 
high-fat diet-fed Atm-/- mice had significantly less hepatic fibrosis than Atm+/+ or Atm+/- mice fed the same diet. together, 
these data demonstrate a prominent role for the AtM pathway in the response to hepatic fat accumulation and link AtM 
activation to fatty liver-induced steatoapoptosis and fibrosis, key features of NAFLD progression.
The DNA damage checkpoint protein ATM 
promotes hepatocellular apoptosis  
and fibrosis in a mouse model  
of non-alcoholic fatty liver disease
erin K. Daugherity,1,2 Gabriel Balmus,2 Ahmed Al Saei,2 elizabeth S. Moore,2 Delbert Abi Abdallah,3 Arlin B. Rogers,4  
Robert S. Weiss2,†,* and Kirk J. Maurer1,2,†,*
1Center for Animal Resources and education; Cornell University; Ithaca, NY USA; 2Department of Biomedical Sciences; Cornell University; Ithaca, NY USA; 3Department of 
Microbiology and Immunology; Cornell University; Ithaca, NY USA; 4Department of pathology and Laboratory Medicine; University of North Carolina; Chapel Hill, NC USA
†these authors contributed equally to this work.
Key words: nonalcoholic fatty liver disease, oxidative stress, ATM, steatoapoptosis, hepatic fibrosis
Abbreviations: NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; HCC, hepatocellular carcinoma; 
FFA, free fatty acids; ROS, reactive oxygen species; ATM, ataxia telangiectasia mutated; DSB, double strand DNA breaks; A-T, 
ataxia telangiectasia; SD, standard diet; HFD, high-fat diet; IR, ionizing radiation; PUMA, p53 upregulated modulator  
of apoptosis; TUNEL, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling;  
8-OHG, 8-hydroxyguanosine; DHR, dihydrorhodamine 123
of NASH patients develop cirrhosis and may progress to hepa-
tocellular carcinoma (HCC) or liver failure.1,2,4 There is a clear 
link between dietary fat consumption and fatty liver disease; 
however, the factors that promote the progression of NAFLD 
to NASH and its associated complications currently are not well 
understood.2,5-7
During NAFLD/NASH, an excessive amount of nonesteri-
fied free fatty acids (FFAs) overwhelm the ability of the liver to 
convert FFAs to triglycerides, resulting in apoptotic cell death, 
a process known as steato- or lipoapoptosis.8,9 In both humans 
and animal models, hepatocyte apoptosis correlates with NASH 
severity and fibrosis stage, suggesting that steatoapoptosis plays 
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 compared with SD-fed mice (n = 3) 
(Fig. 1A; *p < 0.05). Superoxide levels, as measured by DHR 
staining, were also significantly increased in hepatocytes from 
HFD-fed mice as compared with those from SD-fed animals 
(Fig. 1B and C; *p = 0.01). Quantitative PCR analysis of the 
NADPH oxidase p22phox gene, which plays a central role in 





 and superoxide quantification, there were signifi-
cant increases in p22phox expression in livers from HFD-fed mice 
compared with those from mice fed SD (Fig. 1D; *p = 0.002). 
These data indicate that HFD feeding causes increased oxidative 
stress in hepatocytes.
High-fat diet feeding induces hepatomegaly, steatohepatitis 
and ATM activation and promotes hepatic fibrosis in an Atm-
dependent manner. ATM activation plays an important role in 
the cellular response to ROS, and A-T patients display increased 
sensitivity to oxidative stress.18,19,22 We therefore assessed ATM 
pathway activation in mice following HFD feeding via immu-
nofluorescent staining of liver sections using an antibody that 
detects phosphorylated, active ATM (pS1987 of mouse ATM, 
corresponding to pS1981 of human ATM).23 Hepatocytes from 
Atm+ (Atm+/+ and Atm+/-) HFD-fed mice displayed both nuclear 
and cytoplasmic foci containing p-ATM, while hepatocytes from 
Atm+ SD-fed mice did not, confirming hepatic ATM activation 
in the Atm+ HFD-fed group (Fig. 2A). The majority of the foci 
appeared to be localized to the periphery of the nucleus. The detec-
tion of HFD-induced ATM phosphorylation was specific, as no 
staining was observed in Atm-/- hepatocytes from mice fed either 
diet. We next tested the ability of Atm-deficient mice to respond 
to HFD feeding. Livers were examined grossly and microscopi-
cally after 8 weeks of feeding SD or HFD to determine if HFD 
feeding induced hepatic changes consistent with NAFLD. For all 
measures described below, we observed no significant differences 
between Atm+/+ and Atm+/- mice and, therefore, in most cases 
present combined data for these genotypes under the label Atm+. 
Irrespective of Atm status, there was 100% prevalence of fatty 
liver development in mice fed the HFD (n = 22), whereas all mice 
fed the SD (n = 23) had grossly normal livers (Fig. 2B). Mice 
fed the HFD also had marked increases in liver weight (Fig. 2C; 
*p < 0.0001) but not in total body weight (Fig. 2C and D) com-
pared with mice fed the SD, indicating that the HFD induced 
hepatic fat accumulation independent of obesity. Consistent with 
previous reports in references 24–26, Atm-/- mice had slightly 
lower body weights compared with Atm+ mice regardless of diet 
(Fig. 2D). Upon both H&E and Oil-red-O staining, hepatocytes 
from HFD-fed Atm+/+ and Atm-/- mice displayed marked cellular 
hypertrophy and both microvesicular and macrovesicular steato-
sis (Fig. 3A). In contrast, there was no abnormal hepatic fat accu-
mulation in mice fed the SD. Further, mice fed the HFD had 
significantly higher fatty liver scores compared with SD-fed con-
trols irrespective of Atm genotype (Fig. 3B,*p < 0.0001). These 
data demonstrate that 8 weeks of HFD feeding produced marked 
hepatic steatosis consistent with NAFLD in both Atm-expressing 
and Atm-deficient mice.
Additional hepatic phenotypes resulting from 8 weeks of HFD 
feeding were evaluated based on H&E staining and pico-sirius 
a causative role in disease progression.9-13 The exact mechanisms 
and cellular pathways linking hepatic lipid accumulation to 
steatoapoptosis and the progression of NAFLD/NASH remain 
largely unknown. However, oxidative stress may have a central 
role, as oxidative metabolism is increased in NAFLD patients,14 
and recent studies indicate that saturated FFAs induce apoptosis 
through the generation of reactive oxygen species (ROS).13
Eukaryotic cells protect genomic integrity in part through 
checkpoint mechanisms, including a pathway centered on the 
protein kinase ataxia telangiectasia mutated (ATM), which is 
activated by double-strand DNA breaks (DSB). Once activated, 
ATM phosphorylates intermediary protein substrates, includ-
ing CHK2, p53 and H2AX, leading to cell cycle arrest and 
DNA repair or apoptosis.15 Failure to activate ATM after DNA 
damage leads to defective cell cycle control and impaired DNA 
repair. In humans, ATM deficiency results in the genomic insta-
bility syndrome ataxia telangiectasia (A-T). A-T patients cannot 
respond to DSB properly, resulting in a variety of deleterious 
phenotypes, including cerebellar ataxia, immunodeficiency, 
premature aging, sterility, chromosomal instability, shortened 
lifespan and cancer predisposition.15 ATM is also implicated 
in metabolic disease, characterized by a variety of conditions, 
including insulin resistance, glucose intolerance, elevated serum 
cholesterol and lipid levels and atherosclerosis.16,17 Importantly, 
ATM can be directly activated by ROS independent of DSBs, 
and ROS-induced ATM signaling is associated with phos-
phorylation of only a subset of ATM targets, including p53 and 
CHK2 but not H2AX.17,18 Further, cultured Atm-deficient cells 
are more sensitive to oxidative stress.19 Hepatocytes with excess 
fat are exceptionally vulnerable to oxidative stress and DNA 
damage,4,14,20 but the potential role of ATM in this process is 
unknown.
Due to the increasing prevalence of NAFLD/NASH and the 
clear connection to complications including HCC, the over-
all objective of this study was to establish and characterize an 
inducible animal model capable of mechanistically evaluating 
the interaction between hepatic fat accumulation, DNA dam-
age, oxidative stress and NAFLD/NASH disease progression. 
Our results demonstrate that lipid-laden hepatocytes experience 
increased oxidative stress and undergo ATM-dependent ste-
atoapoptosis, which occurs independently of detectable H2AX 
phosphorylation. These findings provide strong evidence that an 
ATM-mediated DNA damage response contributes to NAFLD 
progression by promoting apoptosis and fibrosis in the liver.
Results
Hepatic oxidative stress is promoted by high-fat diet feeding. 
Feeding mice a high-fat diet with cholesterol and cholic acid 
leads to increased expression of oxidative stress-related genes.21 
We directly measured oxidative stress associated with exces-
sive fat consumption by harvesting hepatocytes from mice fed 
either a standard diet (SD) or a high-fat diet (HFD) for 8 weeks 





drorhodamine (DHR) staining to detect superoxide species. 
Hepatocytes from mice fed the HFD (n = 4) showed significantly 
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Figure 1. High-fat diet feeding induces hepatic oxidative stress. Mice were fed SD or HFD for 8 weeks. Hepatocytes were then harvested and analyzed 
for (A) hydrogen peroxide production (Amplex-Red assay) or (B and C) the presence of superoxide (dihydrorhodamine assay). (A) Comparison of 
hydrogen peroxide levels showed that hepatocytes from mice fed the HFD (n = 4) produced significantly more hydrogen peroxide compared with 
mice fed the SD (n = 3) (*p < 0.05, Student t-test). Scatter dot plot results are expressed as mean ± SeM. (B) Comparison of the mean red fluorescence 
of DHR stained livers from SD and HFD fed groups (n = 3 for both groups) showed that mice fed the HFD displayed significantly more red fluorescence 
than the SD-fed mice (*p = 0.01, Student t-test). Results are expressed as mean ± SeM on a scale of 0–250. (C) Dihydrorhodamine (DHR) fluorescent 
staining of hepatocytes harvested from mice fed the SD (top row) and HFD (bottom row). Scale bars represent 5 μm. (D) Quantitative pCR analysis of 
the NADH/NADpH oxidase p22 phox gene from mice fed SD or HFD demonstrated significant increases in the HFD group compared with the SD group 
(*p = 0.002, Student t-test). Gene expression was normalized to Gapdh expression and was compared by the ΔΔCt method.
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Figure 2. High-fat diet feeding induces grossly evident fatty liver without fat accumulation in other tissues. Atm+ and Atm-/- mice were fed SD or HFD 
for 8 weeks. Liver weight, body weight and liver appearance were evaluated post euthanasia. Hepatocytes were then harvested and analyzed by 
immunofluorescence. (A) Frozen sections of livers from Atm+/+ mice fed SD or HFD and Atm-/- mice fed the HFD were labeled with anti-phospho-AtM 
(p-AtM) antibody and examined by confocal microscopy. Blue fluorescence signals represent DApI stained nuclei and positive p-AtM foci fluoresce 
red. Scale bars represent 2.5 μm. (B) Representative images of liver from SD and HFD groups at the time of euthanasia. Scale bars represent 0.5 cm. 
(C) Comparison of liver weights and (D) total body weights of mice of the indicated genotypes after 8 weeks of HFD or SD feeding showed that mice 
fed the HFD had marked increases in liver weight compared with mice fed the SD (*p < 0.0001, Student t-test). Results are expressed as mean ± SeM.
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Further, all mice fed the HFD, regardless of genotype, had sig-
nificantly higher inflammation (Fig. 3C, *p < 0.05) and fibrosis 
(Fig. 3D, **p < 0.05) scores when compared with mice fed the 
SD. Notably, Atm+ HFD-fed mice developed significantly more 
red staining for collagen. Livers from both Atm+ and Atm-/- mice 
fed the HFD demonstrated moderate, predominantly peri-por-
tal, mixed inflammatory cell infiltrates (Fig. 3A). In contrast, 
there were no hepatic inflammatory lesions in mice fed the SD. 
Figure 3. High-fat diet feeding induces hepatic steatosis and hepatitis regardless of Atm status, but leads to more fibrosis in Atm+ livers. H&e (A, first 
row, scale bars represent 20 μm), Sirius red (A, second row, scale bars represent 20 μm) and oil-Red-o (A, third row, scale bars represent 10 μm) sec-
tions from mice fed SD (n = 20) or HFD (n = 25) for 8 weeks were scored blindly on a scale of 0–4 for fat accumulation (B), inflammation (C) and fibro-
sis (D). Results are expressed as mean ± SeM. Statistical values were obtained using Mann-Whitney-U test followed by Dunn’s post test. Comparison of 
scores between HFD and SD-fed mice showed that regardless of Atm status, mice fed HFD had significantly higher fatty liver (B; *p < 0.0001), inflam-
mation (C; *p < 0.05) and fibrosis (D; **p < 0.05) scores when compared with mice fed SD. Additionally, Atm+ mice fed the HFD developed significantly 
higher fibrosis scores (D, ***p < 0.05) compared with Atm-/- mice. Differences in fibrosis were highlighted by fewer Sirius red-positive foci in Atm-/- mice 
(A, second row, arrows). H&e staining of livers from SD fed Atm+ and Atm-/- mice revealed histologically normal liver, while mice of both genotypes, 
when fed the HFD, displayed cellular hypertrophy and accumulation of microvesicular (arrow head) and macrovesicular (thin arrows) steatosis, and 
portal inflammation (thick arrows). Mice fed the SD did not develop inflammation. oil Red-o staining confirmed the presence of marked lipid accumu-
lation in HFD fed livers.
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nucleotide and marker of oxidative 
nucleic acid damage were then quan-
tified to determine if the elevated oxi-
dative stress in fatty livers resulted in 
hepatocyte DNA damage. There was 
minimal staining for 8-OHG in the 
SD group, while there were multiple 
8-OHG-positive aggregates within 
the nuclei and cytoplasm of hepato-
cytes from HFD-fed mice (Fig. 4A). 
In some nuclei, 8-OHG appeared to 
be localized to the periphery of the 
nucleus. Quantification of 8-OHG-
positive cells showed that there were 
significantly more positive cells in the 
Atm+ and Atm-/- groups fed the HFD 
than in mice fed the SD (Fig. 4B; *p 
= 0.001). There was no significant dif-
ference between Atm+ and Atm-/- HFD-
fed groups. These findings indicate that 
the HFD causes oxidative nucleic acid 
damage in both Atm-expressing and 
Atm-deficient mice.
To determine the nature and extent 
of the DNA damage response induced 
by HFD feeding, we performed immu-
nohistochemistry on liver sections from 
HFD- and SD-fed groups and quanti-
fied the levels of γH2AX, the phosphor-
ylated form of histone H2AX which 
occurs in response to DNA DSBs.27 In 
contrast to our earlier observations of 
HFD feeding-induced ATM phosphor-
ylation (Fig. 2A), there was minimal 
positive staining for H2AX phosphory-
lation in hepatic nuclei from mice of all 
experimental groups (Fig. 4C; Fig. S2; 
*p < 0.0001). Importantly, significant 
increases in γH2AX staining were 
detected in liver sections from control 
mice treated with ionizing radiation. 
Overall, these data demonstrate that there is DNA damage in 
HFD fed hepatocytes without substantial phosphorylation of 
H2AX.
High-fat diet feeding increases Atm-dependent steato-
apoptosis. One of the outcomes of ATM pathway activation is 
apoptosis,15 and steatoapoptosis is important in fatty liver pro-
gression.9,12,13 The induction of apoptosis by HFD feeding was 
evaluated by terminal uridine deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL) staining of liver sections 
(n = 5–10/ group). TUNEL staining detects DNA fragmentation, 
a characteristic feature of apoptotic cells. HFD groups contained 
significantly more TUNEL-positive hepatocytes compared with 
SD groups, which exhibited minimal positive staining (Fig. 5A; 
Fig. S3; *p ≤ 0.0001). Notably, among the HFD-fed mice, Atm+ 
hepatocytes underwent significantly more apoptosis than those 
fibrosis than Atm-/- mice (Fig. 3D, ***p < 0.05). Differences in 
fibrosis development were highlighted by fewer and smaller pico-
sirius red-positive foci in the livers of Atm-/- mice as compared 
with those of Atm+ mice (Fig. 3A). These data demonstrate that 
8 weeks of HFD feeding produces marked steatohepatitis regard-
less of Atm status, and that subsequent fibrosis is dependent, at 
least in part, on ATM.
High-fat diet feeding induces oxidative nucleic acid damage 
but limited histone H2AX phosphorylation. To understand 
the basis for the effects of Atm deficiency on HFD-induced liver 
pathology, we evaluated whether Atm loss affects ROS levels 
in HFD-fed mice. To a similar extent as was observed in Atm+ 





 and superoxide accumulation relative to SD-fed mice 
(Fig. S1). Levels of 8-hydroxyguanosine (8-OHG), an oxidized 
Figure 4. High-fat diet feeding increases hepatic nucleic acid damage but does not induce detect-
able phosphorylation of histone H2AX. (A) Frozen sections of livers from mice fed SD (left) or the 
HFD (right) were labeled with anti-8-hydroxyguanosine (8-oHG) antibody and examined by confocal 
microscopy. Blue fluorescence signals represent DApI stained nuclei and positive 8-oHG foci fluo-
resce red. Scale bars represent 2.5 μm. (B) Quantitation of the experiment described in (A) highlights 
that there were significantly more 8-oGH positive nuclei per 80x field in the Atm+ and Atm-/- groups 
fed the HFD than in the Atm+ group fed the SD (*p = 0.001, Student t-test) (n = 3 in each group). 
Results are expressed as mean ± SeM. the percentage of 8-oHG positive nuclei out of total DApI-
positive nuclei was calculated over three 80x fields. (C) Immunohistochemistry was performed to 
identify phosphorylated histone H2AX in liver sections from HFD and SD-fed mice of the indicated 
genotypes (n = 3/group) and revealed that there was minimal staining in these groups, while there 
was significantly more staining detected in Atm+ livers treated with 10 Gy IR regardless of genotype 
(*p < 0.0001, Student t-test). Data on graph represent mean ± SeM.
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cell clearance stimulate quiescent hepatic stellate cells, triggering 
their transformation to a myofibroblast phenotype and subse-
quent extracellular matrix deposition.11,32
from Atm-/- mice (Fig. 5A; **p < 0.001). To dissect the molecular 
basis for this ATM-dependent apoptotic response to HFD feed-
ing, we used quantitative PCR to measure the expression of the 
DNA damage-responsive, pro-apoptotic gene Puma.28 HFD-fed 
Atm+ mice (n = 12) had increased Puma expression when com-
pared with all other groups, including HFD-fed Atm-deficient 
mice (n = 10–12/group), indicating that PUMA is induced after 
HFD feeding through a mechanism that requires ATM (Fig. 5B; 
*p < 0.01). HFD feeding similarly resulted in increased PUMA 
protein levels as measured by immunoblotting of livers from 
Atm+ HFD-fed mice, and this induction of PUMA was greatly 
reduced in samples from Atm-deficient mice (Fig. 5C). Together, 
these data indicate that HFD feeding induces ATM-dependent 
upregulation of PUMA and hepatocyte apoptosis.
Discussion
NAFLD represents an array of hepatic lesions ranging from 
benign steatosis to hepatic inflammation and cirrhosis. Because 
of the increasing prevalence of this disease, a more thorough 
understanding of the factors involved in NAFLD progression 
is warranted. This study investigated the roles of ATM, a pro-
tein kinase involved in maintaining genomic stability, in a diet-
induced model of NAFLD/NASH. Other models of NASH use 
genetic defects, chemical agents or nutrient depletion to induce 
steatohepatitis and hepatic fibrosis. Nutritional models, such as 
sucrose- and fructose-rich diets, cause only minimal hepatic ste-
atosis and inflammation.21 Conversely, the diet used in this study 
closely recreated the NAFLD phenotype of steatohepatitis and 
fibrosis by coupling high fat with cholesterol and cholic acid. Fat 
accumulation elsewhere in the body was not observed, presum-
ably due to the fat source and the relatively short time period 
mice were fed the HFD.
Eight weeks of HFD feeding caused hepatic phenotypes in 
mice, consistent with NAFLD, including hepatic steatosis and 
oxidative stress indicated by elevated levels of ROS and increased 
expression of p22phox, a gene encoding a subunit of NADPH 
oxidase. Hepatic lipid accumulation is considered an initiating 
factor in NAFLD pathogenesis and renders hepatocytes suscep-
tible to oxidative stress. High levels of oxidative stress correlate 
with increasing severity of liver disease in humans.4 In this study, 
we showed that HFD-induced steatohepatitis and hepatic oxi-
dative stress were present in both Atm+ and Atm-/- mice, which 
recapitulates essential components of NAFLD/NASH and cre-
ates a hepatic environment ideal to study the effects of Atm loss 
on NAFLD progression.
Chronic liver injury results in fibrosis.29,30 After 8 weeks of 
HFD feeding, Atm+ mice exhibited more hepatic fibrosis than 
Atm-/- mice. Interestingly, the same trend was observed for 
hepatic apoptosis, with Atm+ mice exhibiting more hepatocyte 
apoptosis than Atm-/- mice after chronic HFD feeding. This is 
consistent with data indicating that apoptosis contributes to 
fibrosis in NAFLD/NASH progression as well as with in vitro 
studies that suggest a direct link between hepatocyte apoptosis 
and fibrosis.10,12,13,31 Although the precise mechanistic details have 
not been fully resolved, available data indicate that apoptosis and 
Figure 5. High-fat diet feeding induces Atm-dependent steatoapop-
tosis. (A) tUNeL staining to identify apoptotic cells in liver sections 
from mice of the indicated group (n = 5–10/group) was quantified 
and revealed that HFD groups, regardless of genotype, contained 
significantly more tUNeL-positive hepatocyte nuclei compared with 
the SD (*p < 0.0001, Student t-test). Comparison of tUNeL quantifica-
tion from HFD-fed mice showed that hepatocytes from Atm+ mice 
underwent significantly more apoptosis than those from Atm-/- mice 
(**p < 0.001). Data represent mean ± SeM. (B) Quantitative pCR analysis 
of the pro-apoptotic gene Puma from Atm+ and Atm-/- mice fed either 
SD or HFD for 8 weeks demonstrated that the Atm+ HFD mice (n = 12) 
had increased Puma expression when compared with all other groups 
(n = 10–12/ group) (*p < 0.01, Student t-test). (C) total protein lysates 
were prepared from frozen liver section after feeding SD or HFD and 
immunoblotted for pUMA. Liver lysates from untreated (-IR) or ionizing 
radiation treated (+IR, 2 h post-5 Gy) mice were used as negative and 
positive controls respectively. β-actin was used as a loading control.
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predominantly located in the nuclear periphery, and that ATM is 
critical in repairing this damage.40
NASH carries a risk of HCC formation. It is well established 
that apoptosis promotes hepatic fibrosis, and both are key risk 
factors for HCC development, with hepatic fibrosis and cirrhosis 
being present in 80–90% of patients with HCC.30,41,42 In this 
study, steatoapoptosis and fibrosis were observed at highest lev-
els in ATM-expressing HFD-fed mice, indicating that the ATM 
pathway promotes both during hepatic lipid accumulation. 
Although apoptosis is generally regarded as a tumor-suppressing 
mechanism that clears damaged cells at risk of undergoing malig-
nant transformation, there also are several examples of tumor-
promoting effects of apoptosis, including in HCC.43 Here, the 
ultimate effect of reduced fibrosis and apoptosis on tumor devel-
opment could not be determined, because Atm-/- mice develop 
thymic lymphoma at 3–4 mo of age,24-26 preventing long-term 
evaluation of liver carcinogenesis. However, based upon the 
recognized influences of apoptosis and fibrosis during HCC 
development, it is reasonable to hypothesize that the observed 
Atm-dependent increases in these processes could promote 
hepatic carcinogenesis. Therefore, pharmacological inhibition of 
ATM may be beneficial to limit fibrosis formation and NAFLD 
progression.
In summary, our findings suggest that hepatic fat accumula-
tion triggers oxidative stress and activation of an ATM-mediated 
DNA damage response, resulting in steatoapoptosis and hepatic 
fibrosis. Human trials have been inconclusive regarding effective 
therapy for NAFLD, including antioxidants, insulin sensitizers, 
weight loss or a combination of these modalities.44,45 However, 
our data suggest that modulation of ROS levels and ATM activa-
tion may provide novel therapeutic targets to prevent the pro-
gression of NAFLD. The mouse model described here provides 
a system for further experimental evaluation of how candidate 
therapeutics, like the antioxidants NAC and Tempol, which sup-
press the ROS to which ATM responds,46-48 impact fatty liver 
disease.
Materials and Methods
Animal husbandry. Atm-null mice were used on a FVB/N strain 
background.25 Atm+/- mice were intercrossed, and progeny were 
divided into four study groups. In the first and second group, 
Atm+ (Atm+/+ and Atm+/-) and Atm-/- mice were fed a standard diet 
(SD) (<0.05% cholesterol, 0% cholic acid, 5% triglyceride; 7012 
Harlan Teklad LM-485 Mouse/Rat Sterilizable Diet), and in the 
third and fourth groups, Atm+ and Atm-/- mice were fed a high-
fat diet (HFD) (1.0% cholesterol, 0.5% cholic acid, 18% triglyc-
eride; TD.880511, Harlan, Teklad Lab Animal Diets; “Paigen 
diet”) for eight weeks. Initially, both sexes were assessed sepa-
rately; however, no differences were seen between the sexes, and 
male and female data were combined (data not shown). Likewise, 
data from Atm+/- and Atm+/+ mice were initially evaluated inde-
pendently and combined when data indicated there were no dif-
ferences between these groups. A subset of mice was whole-body 
irradiated with 10 Gy irradiation 8 h prior to tissue collection. 
Mice were housed under specific pathogen-free conditions in an 
Differences in fibrosis and steatoapoptosis between HFD-fed 
Atm+ and Atm-/- mice correlated with expression levels of the 
pro-apoptotic gene Puma at both the mRNA and protein levels. 
Excessive ROS production, as seen in this model, may induce 
apoptosis via various pathways, including the intrinsic path-
way of apoptosis, which involves PUMA signaling.11,33 Recent 
studies identify PUMA as an important factor in hepatocyte 
steatoapoptosis, and PUMA inhibition or deficiency leads to 
decreased hepatic apoptosis.33-36 Moreover, hepatic Puma expres-
sion is increased in NASH patients as compared with expres-
sion levels in NAFLD or healthy patients, implicating PUMA in 
fatty liver disease progression, likely through functions related 
to steatoapoptosis and fibrosis formation.9,34 Puma activation 
relies primarily on the DNA damage-inducible transcription 
factor p53.33 ATM is an upstream activator of p53, linking 
ATM to PUMA-mediated apoptosis in a manner consistent 
with the ATM-dependent upregulation of Puma expression in 
this model. We also evaluated components of the extrinsic path-
way of apoptosis, including Fas and Fas receptor, via quantitative 
PCR. There were appreciable increases in Fas receptor expression 
between SD and HFD groups, but the levels were nearly identi-
cal between Atm+ and Atm-/- HFD groups (Fig. S4). Further, 
there was no detectable expression of Fas ligand in any treatment 
group (data not shown). Although we cannot entirely rule out 
involvement of the extrinsic pathway of apoptosis in high-fat-
mediated apoptotic cell death, it does not appear to account 
for differences observed in hepatocyte death between HFD fed 
Atm+ and Atm-/- mice.
One of the most common causes of hepatic genomic insta-
bility is ROS-induced DNA damage.37,38 In this study, chronic 
HFD feeding caused oxidative nucleic acid damage regardless 
of Atm status as evidenced by the similar percent of 8-OHG-
positive cells in HFD-fed Atm+ and Atm-/- mice. Interestingly, 
phosphorylation of histone H2AX, a marker of DNA DSBs, was 
not detectably induced in the HFD groups. γH2AX-positive 
hepatocytes were present in IR-treated control samples, dem-
onstrating that the immunohistochemical assay for γH2AX 
was functional. Thus, hepatocytes are capable of phosphorylat-
ing H2AX but do not do so to a detectable level in response to 
HFD feeding. Studies show that ROS-induced ATM activation 
can occur in the absence of DNA DSBs, and this is associated 
with phosphorylation of only a subset of ATM targets that does 
not include H2AX.17,18 Taken together, these data suggest that 
ATM-mediated fatty liver phenotypes may be the result of an 
oxidative stress response rather than the classical γH2AX associ-
ated signaling pathway. The observation of phospho-ATM in the 
cytoplasm of fat-laden hepatocytes provides further support for 
a ROS-mediated mechanism of ATM activation.17 Within the 
nucleus, both 8-OHG and p-ATM seemed to be more abun-
dant at the nuclear periphery. One hypothesis to explain the 
observed localization of 8-OHG is that the low permeability of 
reactive oxygen species limits their mobility through the nuclear 
membrane, thus creating the most extensive oxidative damage 
at the nuclear periphery.39 The observed staining patterns also 
may relate to previous in vitro studies, demonstrating that oxida-
tive damage preferentially occurs in heterochromatin, which is 
© 2012 Landes Bioscience.
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Hydrogen peroxide, 8-hydroxyguanosine, phospho-ATM 





 levels were detected using the Amplex Red Hydrogen 
Peroxide/Peroxidase Assay Kit (Molecular Probes). Single-cell 
hepatocyte suspensions were obtained from fresh liver sam-
ples, and red blood cells were removed using a percol gradient. 
Reactions containing 50 μM Amplex Red reagent, 0.1 U/ mL 
horse radish peroxidase and 1 x 105 hepatocytes in 50 mM sodium 
phosphate buffer, pH 7.4, were incubated for 30 min at 37°C. 
Fluorescence was measured with a microplate reader using excita-





 levels were determined in relationship to a standard curve.
Hepatic superoxide was visualized using dihydrorhoda-
mine 123 (DHR) (Molecular Probes/Invitrogen) fluorescent 





Hepatocytes were washed in 1x PBS, resuspended in media and 
incubated with 100 μL of 25 μg/mL solution of DHR in the 
dark at 37°C for 20 min. Hepatocytes were counted, and cyto-
spins were performed with 1 x 106 cells. Images were obtained 
via confocal microscopy using excitation 596 nm, detection at 
600–650 nm and magnification 63x.51 Nuclei were stained with 
4',6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich). Mean 
red fluorescent values were determined by averaging the fluores-
cence within a set number of pixels placed over five areas within 
a 63x field, three fields per sample. Results were expressed on a 
scale of 0–250.
DNA damage in hepatocytes was detected using an anti-8-hy-
droxyguanosine (8-OHG) antibody (ab10802, Abcam), and the 
presence of phosphorylated ATM in hepatocytes was detected 
using an anti-phospho-Serine1981-ATM (p-ATM) antibody 
(#200-301-400, Rockland) on frozen liver sections. Liver sam-
ples were embedded in Tissue-Tek O.C.T., flash frozen in liquid 
N
2
 and sectioned at 8–10 μM. Sections were fixed in a mixture of 
three parts acetone, one part pure ethanol and washed in 1x PBS. 
Sections were blocked with casein/10% donkey serum for 20 min 
at room temperature, washed in 1x PBS and then incubated with 
goat anti-8-OHG antibody (1:100 dilution) for 1 h at 37°C or 
mouse anti-p-ATM antibody (1:200 dilution) overnight at 4°C 
in a humidifying chamber. Sections were washed in 1x PBS and 
treated with secondary antibodies labeled with Texas Red (1:500 
dilution; Jackson ImmunoResearch). Nuclei were labeled with 
4',6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich). For 
8-OHG quantification, the percentage of positive 8-OHG cells 
was calculated over three 80x fields from three different mice per 
group.
Western blotting. Cells were harvested and solubilized in 
RIPA buffer as described previously in reference 52, followed 
by sonication. Total protein was quantified by Bradford assay, 
resolved on 6% to 14% SDS-PAGE gels, and subjected to immu-
noblotting using antibodies against PUMA (Abcam, #ab9643) 
and anti-β-actin (Sigma, #A5441). Western blot imaging and 
quantification was performed using a Versa Doc Imaging System 
(Bio-Rad Laboratories).
Statistical analyses. Parametric data were analyzed utiliz-
ing one-way analysis of variance followed by Tukey’s post-
test or by t-test. Nonparametric data were analyzed by the 
Association for the Assessment and Accreditation of Laboratory 
Animal Care International accredited facility. Mice received food 
and water ad libitum. All protocols were approved by the Cornell 
University Institutional Animal Care and Use Committee.
Tissue harvest and histopathology. After eight weeks of HFD 
or SD feeding, mice were euthanized with CO
2
. The liver was 
removed aseptically and weighed. Approximately 30 mg of liver 
was flash frozen in both liquid N
2
 and in Tissue-Tek O.C.T. 
(Sakura Finetek) and stored at -80°C. The remainder of the liver 
was fixed in 10% neutral buffered formalin. Tissues were pro-
cessed, paraffin embedded, cut into 4–5 μ sections and stained 
with hematoxylin and eosin. Additional liver sections were 
stained with Oil Red-O or pico- Sirius Red. Tissues were evalu-
ated by a pathologist blinded to sample identity and study design. 
Hepatic fat accumulation, inflammation and fibrosis were scored 
on an ascending 0–4 scale.49
Quantitative PCR. RNA was extracted from liver samples 
using the E.Z.N.A Total RNA Kit (Omega), and residual genomic 
DNA was removed with DNase treatment (Omega), using the 
manufacturer’s recommendations. Total RNA (1–2 μg) was used 
for synthesis of complimentary DNA (qScript cDNA Synthesis 
Kit; Quanta Biosciences). PerfeCTa SYBR Green FastMix, Low 
ROX quantitative polymerase chain reaction (PCR) Master Mix 
(Quanta Biosciences) was used for the quantitative PCR reac-
tion utilizing Applied Biosystems 7500. Gene expression levels 
were normalized to Gapdh expression, and quantification was 
determined via the ΔΔC
T
 method using the Atm+ SD group as 
the comparative delta value (expression of 1). Error bars repre-
sent relative log conversion of standard error as described previ-
ously in reference 50. Primer sets were acquired (Integrated DNA 
Technologies) as follows: glyceraldehyde-3-phosphate dehydroge-
nase (Gapdh), p22phox, Puma, Fas and Fas Receptor (Table S1).
Immunohistochemistry. Hepatocyte apoptosis was quan-
tified by terminal deoxynucleotidyl transferase-mediated 
deoxyuridine triphosphate nick-end labeling per manufactur-
ers recommendation (TUNEL; ApopTag Peroxidase In Situ 
Apoptosis Detection Kit; Millipore). Positive staining was 
detected with 3,3'-diaminobenzidine tetrahydrochloride (DAB) 
(Invitrogen) and sections were counterstained with hematoxylin. 
Liver sections from 5 animals per group were TUNEL stained. 
For each section, four 20x fields were chosen randomly and the 
number of TUNEL-positive and TUNEL-negative hepatocytes 
were quantified.
Immunohistologic detection of phosphorylated H2AX was 
determined on formalin-fixed, paraffin embedded liver sections. 
Briefly, sections were deparaffinized and rehydrated. Antigen 
retrieval was performed by heating the samples to 95°C in 





 for 10 min and blocked with 4% bovine serum albumin 
and 20% Tween in 1x TBS at room temperature and then incu-
bated overnight with primary antibody (1:200 dilution; mouse 
monoclonal anti-γH2AX antibody; Millipore) at 4°C. Slides 
were treated with biotinylated secondary antibody for 20 min 
and detected with Histostain Kit (Invitrogen). Quantification of 
positive γH2AX hepatocytes was performed in the same manner 
described for TUNEL staining.
© 2012 Landes Bioscience.
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